Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ebony A Miller

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancer Immunology, Immunotherapy : CII|December 6, 2022
Cxcr3 constrains pancreatic cancer dissemination through instructing T cell fateAdam L Burrack, Ellen J Spartz, Meagan R Rollins, et al.
Nature Communications|February 1, 2023
Germline T cell receptor exchange results in physiological T cell development and functionMeagan R Rollins, Jackson F Raynor, Ebony A Miller, et al.
JCI Insight|April 8, 2022
Distinct myeloid antigen-presenting cells dictate differential fates of tumor-specific CD8+ T cells in pancreatic cancerAdam L Burrack, Zoe C Schmiechen, Michael T Patterson, et al.
Cell Reports|July 4, 2023
Tumor-specific CD4 T cells instruct monocyte fate in pancreatic ductal adenocarcinomaMichael T Patterson, Adam L Burrack, Yingzheng Xu, et al.
Cancer Immunology Research|March 12, 2025
IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8+ T cells Infiltrating Pancreatic Ductal AdenocarcinomaZoe C Schmiechen, Hezkiel A Nanda, Adam L Burrack, et al.
Science Immunology|June 26, 2026
T<sub>reg</sub> cells promote immunotherapy-induced immune evasion by restraining CD4 T cell control of MHC-I-deficient metastatic pancreatic cancerZoe C Schmiechen, Eduardo Cruz-Hinojoza, Audrey L Hilk, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancer Immunology, Immunotherapy : CII|December 6, 2022
Cxcr3 constrains pancreatic cancer dissemination through instructing T cell fateAdam L Burrack, Ellen J Spartz, Meagan R Rollins, et al.
Nature Communications|February 1, 2023
Germline T cell receptor exchange results in physiological T cell development and functionMeagan R Rollins, Jackson F Raynor, Ebony A Miller, et al.
JCI Insight|April 8, 2022
Distinct myeloid antigen-presenting cells dictate differential fates of tumor-specific CD8+ T cells in pancreatic cancerAdam L Burrack, Zoe C Schmiechen, Michael T Patterson, et al.
Cell Reports|July 4, 2023
Tumor-specific CD4 T cells instruct monocyte fate in pancreatic ductal adenocarcinomaMichael T Patterson, Adam L Burrack, Yingzheng Xu, et al.
Cancer Immunology Research|March 12, 2025
IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8+ T cells Infiltrating Pancreatic Ductal AdenocarcinomaZoe C Schmiechen, Hezkiel A Nanda, Adam L Burrack, et al.
Science Immunology|June 26, 2026
T<sub>reg</sub> cells promote immunotherapy-induced immune evasion by restraining CD4 T cell control of MHC-I-deficient metastatic pancreatic cancerZoe C Schmiechen, Eduardo Cruz-Hinojoza, Audrey L Hilk, et al.
Pageof 1